Please provide your email address to receive an email when new articles are posted on . In a video, Jay B. Wish, MD, clinical medicine professor at Indiana University School of Medicine reports the ...
THOUSAND OAKS, Calif., Jan. 16, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced top-line results of the Phase 3 Aranesp® (darbepoetin alfa) RED-HF® (Reduction of Events With Darbepoetin Alfa ...
The studies compared the efficacy and safety of vadadustat to darbepoetin alfa in adult patients on dialysis with anemia due to CKD. Positive topline data were announced from the global phase 3 INNO 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results